AI companies using agentic healthcare models are lobbying federal officials to create a national licensing framework.
Developers say a single federal pathway would let advanced AI tools operate nationwide without navigating different rules in every state. According to reporting by Inside Health Policy (IHP), state‑by‑state approval slows innovation and makes

